Use of phage display to probe the evolution of binding specificity and affinity in integrins.
暂无分享,去创建一个
Renhao Li | W. DeGrado | Renhao Li | J. Bennett | R. Hoess | William F DeGrado | Joel S Bennett | Ronald H Hoess
[1] G. Wagner,et al. Structure of the RGD protein decorsin: conserved motif and distinct function in leech proteins that affect blood clotting. , 1994, Science.
[2] E Ruoslahti,et al. Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library , 1994, The Journal of cell biology.
[3] R. Huber,et al. Crystal structure determination, refinement and the molecular model of the alpha-amylase inhibitor Hoe-467A. , 1986, Journal of molecular biology.
[4] Jerry Avorn. Technology , 1929, Nature.
[5] C. E. Peishoff,et al. Conformations of Arg-Gly-Asp containing heterodetic cyclic peptides: solution and crystal studies , 1992 .
[6] H. Hinz,et al. Thermodynamics of unfolding of the alpha-amylase inhibitor tendamistat. Correlations between accessible surface area and heat capacity. , 1992, Journal of molecular biology.
[7] W. DeGrado,et al. Agonist-activated αvβ3 on Platelets and Lymphocytes Binds to the Matrix Protein Osteopontin* , 1997, The Journal of Biological Chemistry.
[8] M. Saraste,et al. FEBS Lett , 2000 .
[9] R. Hoess,et al. Tendamistat as a scaffold for conformationally constrained phage peptide libraries. , 1995, Journal of molecular biology.
[10] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[11] J. Desmet,et al. Development and application of cytotoxic T lymphocyte‐associated antigen 4 as a protein scaffold for the generation of novel binding ligands , 2000, FEBS letters.
[12] Erkki Ruoslahti,et al. Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins , 1995, Bio/Technology.
[13] W. DeGrado,et al. Type II‘ to Type I β-Turn Swap Changes Specificity for Integrins , 1996 .
[14] S. Goodman,et al. Definition of an Unexpected Ligand Recognition Motif for αvβ6 Integrin* , 1999, The Journal of Biological Chemistry.
[15] R. Kodandapani,et al. Crystal Structure of the OPG2 Fab , 1995, The Journal of Biological Chemistry.
[16] John McCafferty,et al. Phage display of peptides and proteins : a laboratory manual , 1996 .
[17] Jonathan Boyd,et al. The three-dimensional structure of the tenth type III module of fibronectin: An insight into RGD-mediated interactions , 1992, Cell.
[18] T. Kiefhaber,et al. Folding of the disulfide-bonded beta-sheet protein tendamistat: rapid two-state folding without hydrophobic collapse. , 1997, Journal of molecular biology.
[19] K. Sekiguchi,et al. Peptide ligands for integrin alpha v beta 3 selected from random phage display libraries. , 1995, Biochemistry.
[20] K Wüthrich,et al. Determination of the complete three-dimensional structure of the alpha-amylase inhibitor tendamistat in aqueous solution by nuclear magnetic resonance and distance geometry. , 1988, Journal of molecular biology.
[21] R. Huber,et al. The crystal structure of porcine pancreatic alpha-amylase in complex with the microbial inhibitor Tendamistat. , 1995, Journal of molecular biology.
[22] F. Schumann,et al. Are β-Amino Acids γ-Turn Mimetics? Exploring A New Design Principle for Bioactive Cyclopeptides , 2000 .
[23] S. Niewiarowski,et al. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. , 1994, Seminars in hematology.
[24] W. DeGrado,et al. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library , 1992, Proteins.
[25] W A Hendrickson,et al. Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. , 1992, Science.
[26] J. Calvete,et al. Structural Requirements of Echistatin for the Recognition of αvβ3 and α5β1Integrins* , 1999, The Journal of Biological Chemistry.
[27] B. Felding-Habermann,et al. Molecular Determinants of Arg-Gly-Asp Ligand Specificity for β3 Integrins* , 1997, The Journal of Biological Chemistry.
[28] Jeffrey W. Smith,et al. Protein Loop Grafting to Construct a Variant of Tissue-type Plasminogen Activator That Binds Platelet Integrin αIIbβ3(*) , 1995, The Journal of Biological Chemistry.
[29] W. F. Gunsteren,et al. β-Hairpin stability and folding: Molecular dynamics studies of the first β-hairpin of tendamistat , 2000 .
[30] Jung Weon Lee,et al. New aspects of integrin signaling in cancer. , 2000, Seminars in cancer biology.
[31] Horst Kessler,et al. Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the αvβ3 Integrin for a New Cancer Therapy , 1997 .
[32] F. Young. Biochemistry , 1955, The Indian Medical Gazette.
[33] T. Kiefhaber,et al. Apparent two-state tendamistat folding is a sequential process along a defined route. , 2001, Journal of molecular biology.